BTA
Click for more information
0.00% 57.0¢ biota holdings limited

I agree 20, but my gut-feeling is that Glaxo will be the...

  1. jessie1
    8,256 Posts.
    clock Created with Sketch.
    07/04/10
    13:09
    Post #: 6541446
    I agree 20, but my gut-feeling is that Glaxo will be the incumbent Lani licensee. If this is the case, it's not necessarily going to be a worse deal than it could be with Roche...we'll know soon enough.

    Again, if Glaxo is the incumbent, I'd hope there would have been early negotiations with Roche in order to use this as a bargaining chip with Glaxo.
    BTA Price at posting: $2.27 Sentiment: LT Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

FHE Frontier Energy lines up $215 million debt financing from Mike Cannon-Brookes-backed Infradebt
right-arrow Created with Sketch.
PEC Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil
right-arrow Created with Sketch.
BGL Bellevue aims for 45% production increase by FY 2028, announces $150M placement
right-arrow Created with Sketch.
HRZ Horizon firms up ore reserve for Boorara ahead of FY25 Q1 development decision
right-arrow Created with Sketch.
NEWS Warren Tredrea’s weekly sports business wrap: the latest on business in sport
right-arrow Created with Sketch.
LKE Lake Resources implies news article on job cuts made up; non-core sales "not material" and no rule 15.7 breach
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.